Serial 79225044

Live / Registered — Registered — international registration renewed (as of 20 Jun 2025)

What this means for you

Registered since 12 Feb 2019. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79225044
Registration number
5671918
Mark type
Design / logo
Filed
11 Oct 2017
Published for opposition
27 Nov 2018
Registered
12 Feb 2019
Attorney of record
Shannon Marie McKeon

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for use in enzyme replacement therapy; pharmaceutical and veterinary preparations, namely, vaccines for the treatment of physical and mental illness; pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for the prevention and treatment of disorders of the endocrine system, growth hormone deficiencies, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor(FGFR)-related skeletal disorders, oncological disorders, ophthalmologic disorders, infectious diseases, enzyme replacement therapy, anti-inflammatory diseases, pain, respiratory system disorders, autoimmune disorders, vaccines, non-alcoholic steatohepatitis, brain diseases, bone diseases, CNS diseases, myopathies, obesity, wounds healing, the hormonal system disorders, namely, growth hormone deficiencies, diabetes and angiogenesis, the ophthalmological system disorders, namely, angiogenesis, the angiogenic system disorders, the central nervous system disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, the immune system disorders, namely, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, the cardio-vascular system diseases, the metabolic system disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, the respiratory system, the musculo-skeletal system disorders, namely, growth hormone deficiencies, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, the genitourinary system disorders, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory disorders, namely, anti-inflammatories; pharmaceutical preparations for use in dermatology, namely, dermatitis, eczema, psoriasis; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in in ophthalmology; pharmaceutical preparations for use in the treatment of gastroenterological disorders; sanitary preparations for medical purposes, namely, sanitizing wipes, disinfectants for medical instruments, adhesive tapes for medical purposes, dietetic foods, namely, dietetic sugar substitutes adapted for medical use, all-purpose disinfectants for sanitary purposes; fungicides, herbicides
  • Class 042 — Scientific and technological services: Scientific research within the medical, pharmaceutical and bacteriological area and providing scientific consultancy and information in relation to the aforementioned scientific research, conducting of tests regarding medical applications, namely, conducting clinical trials for others, packaging design, designing and development of medical equipment, designing pharmaceutical and medical preparations, preparation of pharmaceutical formulations, namely, pharmaceutical products development, design and development of granulation technology and tablet technology and providing scientific consultancy and information relating to the design and development of granulation technology and tablet technology
  • Class 045 — Legal and security services: Licensing of industrial property; legal services

Owner

Prosecution history

  • 20 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
  • 20 Jun 2025 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
  • 02 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 12 Feb 2025 — TEAS SECTION 71 & 15 RECEIVED
  • 10 Mar 2024 — NEW REPRESENTATIVE AT IB RECEIVED
  • 12 Feb 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
  • 24 Dec 2021 — NEW REPRESENTATIVE AT IB RECEIVED
  • 28 Oct 2021 — NEW REPRESENTATIVE AT IB RECEIVED
  • 21 Jun 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB
  • 04 Jun 2019 — FINAL DISPOSITION NOTICE SENT TO IB
  • 04 Jun 2019 — FINAL DISPOSITION PROCESSED
  • 12 May 2019 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
  • 12 Feb 2019 — REGISTERED-PRINCIPAL REGISTER
  • 27 Nov 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 27 Nov 2018 — PUBLISHED FOR OPPOSITION

View this trademark record on Marksy